EPLAW PATENT BLOG

NL – Sandoz v. Eli Lilly – Alimta® / pemetrexed

Posted: January 24th, 2019

Sandoz International GmbH v. Eli Lilli and Company, District Court The Hague, The Netherlands, 16 January 2019, Case no. ECLI:NL:RBDHA:2019:321

Lilly holds European patent 1 313 508 B1 (hereafter: EP 508), entitled ‘Combination containing an antifolate and methylmalonic acid lowering agent’. Sandoz in tries to have EP 508 revoked due to lack of inventive step. The attempt fails. Lily rightfully states that Sandoz takes an incorrect starting point for the assessment of inventive step.

A copy of the decision (in Dutch) can be read here.

Leave a Reply